Take Advantage of the Read-and-Publish Agreement between participating members of the JMLA/JPLA consortium and RUP

Rockefeller University Press (RUP) has joined an unlimited Read-and-Publish agreement with participating members of the JMLA/JPLA consortium. This opt-in agreement covers RUP's three hybrid journals for participating libraries: Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM), and Journal of General Physiology (JGP).

How researchers immediately benefit from the agreement:

• Read: Unlimited access to all content published in JCB, JEM, and JGP immediately after publication.
• Publish: 100% coverage of the Immediate Open Access fees on any accepted manuscript when the primary corresponding author is based at a participating institution. There is no limit to the number of articles that may be published as a part of the deal.

Open Access research articles are published under a CC-BY license, directly deposited to PubMed Central (PMC) and subsequently to Europe PMC, and archived in LOCKSS/CLOCKSS.

How authors can take advantage:

• The primary corresponding author must be affiliated with an eligible JMLA/JPLA member institution that has elected to participate in this Read-and-Publish agreement, and the author must publish under this affiliation.
• Upon submitting their article, the author will be asked to validate their institution. The participating JMLA/JPLA institution must be indicated.
• The article must be accepted between January 1, 2023 and December 31, 2025.
• If invited to submit a final revision, the author will receive a request to sign our license once the revision is received.
• Authors who publish in RUP journals always retain copyright ownership or have the ability to set the copyright owner as their institutions when required.

Participating Members:

If your institution is not listed above, please contact [email protected] to see if your article is eligible.